Cannexa T10:C10
Standardised oral solution. Balanced THC to CBD ratio formulated for consistent dosing.
Formulation: Oral solution (30ml)Concentration: 10mg/ml THC, 10mg/ml CBDOrigin: EU-GMP Certified
Cannexa Franchise
Cannexa
Cannexa is the cannabinoid-based medical products franchise of Altanova Pharma Group AG, focused on regulated medical-channel access, compliant sourcing and pharmaceutical-quality standards for chronic disease areas where cannabinoid-based therapies may have a role.
Quality standards
EU-GMP supplier qualification and full batch traceability.
Medical channel
Exclusive distribution via licensed pharmacies.
Safety monitoring
Active pharmacovigilance and ElViS integration.
Chronic Disease Areas
ChronicPainManagement
Neurology /MSSpasticity
OncologySupportiveCare
PalliativeCare
Formulation Portfolio
The Cannexa product range is manufactured under EU-GMP standards and dispensed strictly on medical prescription. Product availability is subject to Swissmedic and cantonal authorisations.
* Note: The product images displayed below are design concepts.
Cannexa C100
Standardised hard capsules. High CBD profile designed for prolonged clinical effect without psychotropic activity.
Formulation: Capsules (30 per pack)Concentration: 100mg CBD per capsuleOrigin: EU-GMP Certified
Cannexa C50
Standardised hard capsules. Medium CBD profile for sustained relief.
Formulation: Capsules (30 per pack)Concentration: 50mg CBD per capsuleOrigin: EU-GMP Certified